Emergent BioSolutions (EBS) EBT (2011 - 2026)
Emergent BioSolutions' EBT was -$166.3 million in Q2 2026, compared with -$16.8 million a year earlier.
Powered by 
Analysis
Emergent BioSolutions (EBS) EBT (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, Emergent BioSolutions' EBT was -$146 million through Jun 30, 2026; for FY2025, it came in at $82.8 million.
- EBT shows a five-year compound annual growth rate of -27.4% (FY2020 to FY2025).
- In earlier years, EBT was -$142.9 million in FY2024, -$731.2 million in FY2023, -$219 million in FY2022 and $303.2 million in FY2021 (-26.4%).
- The Q2 2026 figure marks the lowest quarterly EBT since Q2 2024.
- Per Business Quant data, EBS's EBT in the three quarters before Q2 2026 was $13.4 million (Q1 2026), -$50.7 million (Q4 2025) and $57.6 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,149.75 Bn | 1,118.34 Bn | 19.71 Bn | 9.25 Bn |
| 2 | Johnson & Johnson | 623.95 Bn | 542.48 Bn | 17.26 Bn | 6.75 Bn |
| 3 | AbbVie | 509.37 Bn | 482.48 Bn | 12.70 Bn | 4.28 Bn |
| 4 | Merck | 366.05 Bn | 320.43 Bn | 12.21 Bn | -683.00 Mn |
| 5 | Novartis Ag | 297.67 Bn | 261.66 Bn | 11.24 Bn | 4.27 Bn |
| 6 | Astrazeneca | 261.57 Bn | 235.26 Bn | 12.86 Bn | 2.80 Bn |
| 7 | Amgen | 235.98 Bn | 191.38 Bn | 7.24 Bn | 2.77 Bn |
| 8 | Gilead Sciences | 194.26 Bn | 168.45 Bn | 6.22 Bn | -10.25 Bn |
| 9 | Pfizer | 171.94 Bn | 118.58 Bn | 10.94 Bn | -653.00 Mn |
| 10 | Emergent BioSolutions | 325.60 Mn | -425.30 Mn | 137.20 Mn | -166.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -166.30 Mn |
| Mar 31, 2026 | 13.40 Mn |
| Dec 31, 2025 | -50.70 Mn |
| Sep 30, 2025 | 57.60 Mn |
| Jun 30, 2025 | -16.80 Mn |
| Mar 31, 2025 | 92.70 Mn |
| Dec 31, 2024 | -27.60 Mn |
| Sep 30, 2024 | 142.40 Mn |
| Jun 30, 2024 | -269.80 Mn |
| Mar 31, 2024 | 12.10 Mn |
| Dec 31, 2023 | -54.50 Mn |
| Sep 30, 2023 | -265.90 Mn |
| Jun 30, 2023 | -250.20 Mn |
| Mar 31, 2023 | -160.60 Mn |
| Dec 31, 2022 | -61.40 Mn |
| Sep 30, 2022 | -67.20 Mn |
| Jun 30, 2022 | -82.80 Mn |
| Mar 31, 2022 | -3.80 Mn |
| Dec 31, 2021 | 256.30 Mn |
| Sep 30, 2021 | -45.50 Mn |
API Access
Emergent BioSolutions EBT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();